Karmanos Cancer Center (Site 109) — Detroit, Michigan

Karmanos Cancer Center (Site 109) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Center (Site 109) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Sponsors: J-Pharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Center (Site 109)?

Karmanos Cancer Center (Site 109) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Center (Site 109) conducted?

Karmanos Cancer Center (Site 109) has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Is Karmanos Cancer Center (Site 109) accredited by Crixeo Health?

Karmanos Cancer Center (Site 109) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Center (Site 109)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.